News & Analysis on Clinical Trial Services & Contract Research And Development
A team of drug researchers are exploring the possibility of extracting chemical compounds from marine organisms that live in deep-sea reefs, which have the potential to treat human diseases such as cancer and Alzheimer's.
Pfizer has sold a large manufacturing plant in Puerto Rico to biopharmaceutical firm Abraxis for $32.5m (€25.4m), as it continues to consolidate its manufacturing operations.
US scientists have uncovered a mechanism of action that explains how cells respond to DNA damage and other stresses that if disrupted can cause cancer. The discovery could lead to new diagnostic markers and cancer treatments with fewer side effects.
Biophage has completed the final phase of its CRO business restructuring in preparation to meet the expected demand in immunotoxicity testing, in which its requirement stems from increasing legislation that calls for stricter standards.
Global packaging giant MeadWestvaco has acquired Saint-Gobain Calmar, a manufacturer of plastic dispensing and spraying systems, looking to establish a solid footing in primary packaging.
Biopharmaceutical firm Oragenics has received funding from a US government agency for a technology which promises cost-effective production of commercially important bioactive peptides with unusual structures.
The World Health Organisation is calling for greater transparency in clinical trials by announcing new registration standards for all medical research involving humans.
As it prepares for the launch of GlaxoSmithKline's beta-blocker Coreg (carvedilol) with a controlled release formulation, drug delivery company Flamel saw its bottom line, in the absence of new partners, shift deep into the red in the first quarter of...
A new drug discovery technique, which uses mixed-mode sorbents in process chromatography, has the potential to significantly reduce costs and environmental burdens, especially in the protein purification process.